Phase II Clinical Study of BC006 in Patients With Idiopathic Pulmonary Fibrosis

Abroad (travel likely)RecruitingPHASE2

Conditions

Idiopathic Pulmonary Fibrosis (IPF)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Dragonboat Biopharmaceutical,Co.,Ltd, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Xianfeng Feng) · xianfeng.feng@dragonboatbio.com · (+86)021-50870050

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

Abroad (travel likely)RecruitingPHASE2

Skopje, North Macedonia

Phase 2 Clinical Trial of MNKD-201 (Nintedanib Dry Powder Inhalation) in Patients With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis · Idiopathic Pulmonary Fibrosis (IPF)

Abroad (travel likely)RecruitingPHASE2

Danbury, United States · Windsor, Canada

Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease

Pulmonary Fibrosis, Interstitial Lung Disease · Idiopathic Pulmonary Fibrosis

Abroad (travel likely)RecruitingPHASE2

Aarhus N, Denmark · Copenhagen, Denmark

Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

Abroad (travel likely)RecruitingPHASE2

Dothan, United States · Champaign, United States